In the VERITAC-2 trial, vepdegestrant monotherapy demonstrated a statistically significant and clinically meaningful improvement in PFS compared with fulvestrant among patients with an ESR1 mutation who were previously treated with a CDK4/6 inhibitor plus endocrine therapy
Neither platform changes the underlying pharmacology, which is driven by the compound rather than the service delivering the prescription
received speaker honoraria from Eli Lilly, Gan and Lee Pharmaceuticals and Novo Nordisk
It was observed that treatment of ethanol (5-25 mM) caused decrease in cell viability but in presence of Rotenone, cell viability decreased to a greater extent
2024 Changes to the NJ PAAD and Senior Gold programs: GSK and Eli Lily Participation Medicare and Social Security updates for 2024 2024 Medicare Enrollment Period Medicare Announces Price Negotiations on 10 Prescriptions New and Expanded state assistance programs for Seniors in New Jersey - NJ PAAD, Senior Gold, NJ Freeze & Stay NJ Supporting a loved one on Medicare in New Jersey Five reasons to work with a Medicare Insurance Broker in New Jersey NJ FamilyCare, PAAD, and Senior Gold Renewal- Post COVID-19 Emergency Declaration 6 Ways to Prepare for Medicare if Youre Working Past 65 Medicare updates for 2023